NCI Genomic Characterization Centers

Active Master IDIQ Awarded

Federal agency
Awardees
6
Task orders
3
Obligated
$5,033,427

Vehicle facts

Opportunity
Agency
Combined task order value
  • $5,033,427 Current, with exercised options
  • $8,087,907 Potential, with all options
Last date to order 35% complete
Shared ceiling 3% used
$149,974,285.00

IDV award and task order details come from SAM.gov/FPDS.

About this vehicle

The National Cancer Institute established this Master IDIQ for genomic characterization centers on January 13, 2025, with ordering authority extending through January 12, 2030. The vehicle carries a $149.974 million combined potential value and remains actively available for task orders.

The originating solicitation, posted in December 2022 as a small business sources sought notice under NAICS 541380 (Testing Laboratories and Services), invited qualified small businesses to demonstrate capability in cancer genomics research. The work addresses molecular characterization of somatic and inherited mutations underlying cancer initiation and progression, with the intent to inform tumor development and progression understanding across multiple cancer types. The solicitation framework contemplated a potential set-aside for small business participation, though the final vehicle structure reflects NCI's determination following the sources sought phase.

The source material does not specify the number of awarded task orders, the identity of the prime contractor or contractors, the distribution of set-asides across awarded orders, typical task-order values or durations, places of performance, or the customer funding patterns across NCI or other HHS agencies. No mega-orders or recent ordering momentum data are present in the available information. The vehicle was established approximately one year ago and retains roughly three years and five months of remaining ordering authority, making it available for active pursuit. Interested parties should confirm the current competitive structure, awardee roster, and typical task-order scope through NCI's contracting office before developing an offer strategy.

IDV awards

Latest task orders

Top awardees by obligations

Rank Awardee Obligated Share
1 Infinity Biologix LLC $3,787,259 75%
2 The Washington University $1,246,168 25%

Top funding agencies by obligations

Rank Funding agency Obligated Share
1 Department of Health and Human Services $5,033,427 100%

Obligations by fiscal year

Fiscal year Obligated
FY2026 $5,033,427

Quick answers

What is the NCI Genomic Characterization Centers contract vehicle?

NCI Genomic Characterization Centers is an indefinite delivery, indefinite quantity (IDIQ) contract vehicle run by National Cancer Institute (National Institutes of Health), awarded on January 13, 2025.

Which companies hold NCI Genomic Characterization Centers?

6 companies hold NCI Genomic Characterization Centers's IDV awards, one each. The latest went to Infinity Biologix LLC on January 13, 2025. The awardees whose task orders obligated the most are Infinity Biologix LLC and The Washington University.

How much has been spent through NCI Genomic Characterization Centers?

3 task orders have been placed under NCI Genomic Characterization Centers, obligating $5,033,427.

What is the shared ceiling of NCI Genomic Characterization Centers?

NCI Genomic Characterization Centers's shared ceiling is $149,974,285; its task orders have used 3% of it.

Which agencies use NCI Genomic Characterization Centers the most?

The departments whose task orders under NCI Genomic Characterization Centers obligated the most are Department of Health and Human Services ($5,033,427).

On GovTribe

See this vehicle's full record

  • Every IDV award and task order
  • Funding by agency, awardee, NAICS and set-aside
  • Teaming partners on this vehicle
  • Ask GovTribe AI about this vehicle